首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 食物/飲料 > 機能性食品 > 天然營養補充劑專利策略的相關案例研究
產業/市場分類
食物/飲料 (2730)
水果/蔬菜 (25)
包裝食品 (229)
早餐食品 (14)
(36)
冷凍食品 (13)
乳製品 (141)
汽水 (458)
油肥與脂肪 (35)
保健食品 (228)
保健飲料 (162)
食品服務 (159)
食品添加劑 (195)
茶/咖啡 (115)
酒類 (445)
減肥食品 (27)
零食 (50)
機能性食品 (219)
糖果 (155)
市場調查報告書

天然營養補充劑專利策略的相關案例研究

Natural Nutraceutical Patent Strategy Case Studies

出版商 Business Insights
出版日期 2011年09月 商品編碼 228139
內容資訊 英文 Pages: 146
價格
US $ 2875 PDF by E-mail (Single user license)
US $ 10781 PDF by E-mail (Global license)


天然營養補充劑專利策略的相關案例研究 是由出版商Business Insights在2011年09月所出版的。 這份英文市場調查報告書包含Pages: 146 價格從美金2875起跳。

簡介

由於更嚴格法規的施行,功能食品企業為了證實自家公司品的健康上的有效性,必須進行大量的研究開投資。因此,功能食品企業必須藉由發明專利權來保護投資。

本報告提供創新的營養補充品開發企業8間公司的策略分析,創新的企業各種的專利策略比較對照,專利策略的弱點旨在扭轉商業機會領域,獲得有力投資機會的產品和企業,正在開發的新營養補充品的評估等的詳查結果,為您概述為以下內容。

第1章 執行摘要

  • 專利策略
  • 創新的企業的專利策略
  • 結論

第2章 關於作者

第3章 序論

  • 專利的現狀
  • 本報告的目的

第4章 專利策略

  • 概要
  • 所謂專利
  • 治癒效果專利的必要條件
  • 專利的法律體制
    • 美國
    • 歐洲
    • 專利合作條約
  • 專利費用
    • 歐洲專利局(EPO)專利費
    • 全球知識產權機關(WIPO)專利費用
    • 美國專利商標局(USPTO)費用
  • 天然營養補充劑和NCE的專利申請範圍類別
    • 天然營養補充劑的的健康效果申請往往出現在民間文化形態
    • 天然營養補充劑和藥品的專利策略
    • 天然營養補充劑和藥品的處方專利策略
    • 專利期間的延長
  • NCE專利和天然營養補充劑專利的差異
    • 新化學實體 (NCE)
    • 天然營養補充劑
  • 未來的專利策略

第5章 Evgen Limited

  • 歷史,背景,及經營團隊
  • Evgen公司的知識產權許可證策略
  • 這個領域擁有專利的其他企業

第6章 相關案例研究 - Provexis

  • 歷史,背景,及經營團隊
  • 產品系列
  • DSM擁有的健全的血糖值的專利投資組合

第7章 相關案例研究 - Exichol

  • 歷史,背景,及經營團隊
  • Exichol公司的營養基因學專利策略
  • 營養基因學領域擁有專利的其他發明人

第8章 相關案例研究 - Avesthagen

  • 歷史,背景,及經營團隊
  • Avesthagen公司的天然營養補充劑專利策略
  • Avesthagen公司的「植物性化學成分」PCT (專利合作條約)申請
  • VMSRF (Vittal Mallya Scientific Research Foundation)

第9章 相關案例研究 - Naturalendo Tech

  • 歷史,背景,及經營團隊
  • Naturalendo Tech公司的專利投資組合

第10章 相關案例研究 - Laila Nutraceuticals

  • 歷史,背景,及經營團隊
  • Laila Nutraceuticals公司的專利申請投資組合

第11章 相關案例研究 - WellGen Inc.

  • 歷史,背景,及經營團隊
  • WellGen公司的專利策略
  • 在紅茶萃取物領域的其他的專利

第12章 相關案例研究 - InnoVactiv Inc

  • 歷史,背景,及經營團隊
  • InnoVactiv公司的專利策略

第13章 專利的未來發展預測

  • 概要
  • 高漲的專利活動
  • 許可證策略
  • 新興市場
  • 新技術
    • 藥物傳輸系統
    • 營養基因學
  • 相關的醫藥開發的可能性

目錄

Description

INTRODUCTION

The adoption of more stringent regulation is forcing functional food manufacturers to invest greater resources in research and development in order to fully substantiate product health claims. This investment, added to the level of industry competition, ensures that companies must secure adequate patent protection. This report analyzes the strategies of eight innovative nutraceutical developers.

FEATURES AND BENEFITS

  • Compare and contrast the patent strategies being used by some of the most innovative companies in the nutraceutical industry.
  • Identify weaknesses in patent strategies and possible areas of opportunity.
  • Identify products and companies which offer good investment opportunities.
  • Evaluate new nutraceuticals under development and identify the disease areas and health claims being pursued.
  • Identify key active principles being targeted and their health benefits for certain disease types.

HIGHLIGHTS

The range of companies involved in developing nutraceuticals serves to highlight the different patenting strategies and business models being used. Some manufacturers, such as Evgen, in-license an entire IP portfolio, while companies like Provexis use a mixture of licensed-in IP and in-house development.

Avesthagen's IP business model has evolved, having originally acquired a company that was an early adopter of Ayurvedic medicine patenting. The company has since developed its own in-house screening technologies and patenting, and more recently applied cutting-edge gene transfer techniques to improve the yield of active principles in plant species.

With many modern natural nutraceuticals based upon traditional ingredients that have already been the subject of considerable research and patenting activity, licensing intellectual property will be a key strategic element for any manufacturer wishing to develop successful products.

YOUR KEY QUESTIONS ANSWERED

  • What are the patent strategies of the successful innovative nutraceutical companies?
  • What effect has the recent clamp down on unsubstantiated health claims had on recent patenting activity in nutraceuticals?
  • How do companies use licensing to complement their intellectual property portfolios?
  • Which companies are patenting natural nutraceuticals and natural pharmaceuticals in the same patent applications?
  • Which countries have strong companies involved in developing new nutraceuticals and what are the factors that are encouraging this success?

Table of Contents

Executive Summary

  • Patenting strategies
  • Innovative company patent strategies
  • Conclusions

About the author

  • Disclaimer

Introduction

  • The patents landscape
  • What is this report about?

Patent strategies

  • Introduction
  • What is a patent?
  • Requirement for a therapeutic patent
  • Legal patent frameworks
    • United States
    • European
    • Patent Cooperation Treaty
  • Patenting costs
    • EPO patenting fees
    • WIPO patenting fees
    • USPTO fees
  • Types of patent claims for natural nutraceuticals versus NCEs
    • Health claims of natural nutraceuticals often arise from folklore
    • Process patenting strategies for natural nutraceuticals versus drugs
    • Formulation patenting strategies for nutraceutical versus drugs
    • Patent term extensions
  • Differences in NCE and natural nutraceutical patenting
    • New chemical entities
    • Natural nutraceuticals
  • Future patenting strategies

Evgen Limited

  • History, background and management
    • Evgen strategy overview
    • Product portfolio
  • Evgen's IP licensing-in strategy
    • PharmAgra
    • Kraft Foods
    • Harnessing gene technology for improved production
    • Wider potential for sulforaphane
  • Other companies patenting in this area
    • John Hopkins University
    • Wassen Int Ltd
    • Amway Corp
    • The American Health Foundation
    • Bejo Zaden BV
    • Inventor - Gu Hong Park
    • US Department of Agriculture
    • Seoul National University's SNU R&DB Foundation
    • Provexis Natural Products Limited and Plant Bioscience Limited

Case study - Provexis

  • History, background and management
    • Provexis strategy overview
  • Product portfolio
    • Fruitflow

NSP

3G plantain extract

    • Isothiocyanates
  • DSM's patent portfolio for healthy blood glucose levels

Case study - Exichol

  • History, background and management
    • Exichol strategy overview
  • Exichol's nutrigenomics patenting strategy
  • Other inventors patenting in the nutrigenomics area

Case study - Avesthagen

  • History, background and management
    • Avesthagen's bioNutrition Group
    • Avesthagen's strategy overview
    • Technology and assets
  • Avesthagen's natural nutraceutical patenting strategy
    • Mangosteen - Garcinia mangostana
    • Lagerstroemia speciosa
    • Goji - Lycium barbarum
  • Avesthagen's "phytochemical" PCT applications
    • Salacia extract
    • Salacia, Cinnamomum and Eugenia extracts
    • Trigonella foenum-graecum
    • Punica granatum
    • Gene transfer technology for improved active principle production
  • Vittal Mallya Scientific Research Foundation (VMSRF)

Case study - Naturalendo Tech

  • History, background, management
    • Naturalendo strategy overview
    • Research and development
  • Naturalendo Tech patenting portfolio
    • Phytoestrogens - menopause
    • Insomnia
    • Diabetes
    • Alopecia

Case study - Laila Nutraceuticals

  • History, background and management
    • Laila Nutraceuticals highlights
  • Laila Nutraceuticals patent application portfolio
    • Boswellia serrata
    • Curcuma longa
    • Garcinia mangostana
    • Annona squamosal
    • Ficus hispida
    • Holoptelea integrifolia
    • Aphanamixis polystacha
    • Lagerstromia sp.

Case study - WellGen Inc.

  • History, background and management
    • WellGen highlights
  • WellGen's patenting strategy
    • Black tea extracts
    • Polymethylated flavones for weight management
  • Other patenting in the area of black tea extract

Case study - InnoVactiv Inc

  • History, background and management
    • InnoVactiv highlights:
    • InSea2
  • innoVactiv patenting strategy
    • Other patenting in the area of red and brown algae
    • Peptibal
    • InnoVactiv's cosmeceuticals
    • Cosmeceutical patenting

Patenting future outlook

  • Summary
  • Introduction
  • Increased patent activity
    • Protecting assets
  • Licensing strategies
  • Emerging markets
  • New technologies
    • Delivery systems
    • Nutrigenomics
  • Potential for associated pharmaceutical d
Back to Top